BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31925626)

  • 1. Image screening for maxillo-mandibular actinomycosis with CT,
    Suzuki K; Kurihara J; Kim M; Yanagisawa S; Ogawa M; Makiguchi T; Yokoo S
    Oral Radiol; 2021 Jan; 37(1):46-54. PubMed ID: 31925626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of ¹⁸F-α-methyl tyrosine PET/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma: comparison with ¹⁸F-FDG PET/CT and MRI.
    Kim M; Higuchi T; Arisaka Y; Achmad A; Tokue A; Tominaga H; Miyashita G; Miyazaki H; Negishi A; Yokoo S; Tsushima Y
    Ann Nucl Med; 2013 Jun; 27(5):423-30. PubMed ID: 23436243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intratumoral inflammatory process on 18F-FDG uptake: pathologic and comparative study with 18F-fluoro-α-methyltyrosine PET/CT in oral squamous cell carcinoma.
    Kim M; Achmad A; Higuchi T; Arisaka Y; Yokoo H; Yokoo S; Tsushima Y
    J Nucl Med; 2015 Jan; 56(1):16-21. PubMed ID: 25476535
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Kim M; Higuchi T; Nakajima T; Andriana P; Hirasawa H; Tokue A; Kurihara J; Yokoo S; Tsushima Y
    Oral Radiol; 2019 Sep; 35(3):308-314. PubMed ID: 30778900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of PET/CT 3D visualization of head and neck squamous cell carcinoma extended to mandible.
    Lopez R; Gantet P; Julian A; Hitzel A; Herbault-Barres B; Alshehri S; Payoux P
    J Craniomaxillofac Surg; 2018 May; 46(5):743-748. PubMed ID: 29567343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of metabolic tumor volume of pretreatment
    Kumasaka S; Nakajima T; Arisaka Y; Tokue A; Achmad A; Fukushima Y; Shimizu K; Kaira K; Higuchi T; Tsushima Y
    BMC Med Imaging; 2018 Nov; 18(1):46. PubMed ID: 30477476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-FAMT PET Is Useful to Distinguish between Specific Uptake and Nonspecific Uptake Compared to 18F-Flourodeoxyglucose Position Emission Tomography in Esophageal Cancer Patients.
    Sohda M; Miyazaki T; Honjyo H; Hara K; Ozawa D; Sakai M; Yokobori T; Higuchi T; Tsushima Y; Kuwano H
    Dig Surg; 2018; 35(5):383-388. PubMed ID: 29130979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of sarcoidosis-lymphoma syndrome lesions: a case report on the use of two different positron emission tomography tracers.
    Yudistiro R; Arisaka Y; Tokue A; Nakajima T
    BMC Med Imaging; 2016 Jan; 16():1. PubMed ID: 26746426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FAMT-PET is useful for the diagnosis of lymph node metastasis in operable esophageal squamous cell carcinoma.
    Sohda M; Kato H; Suzuki S; Tanaka N; Sano A; Sakai M; Inose T; Nakajima M; Miyazaki T; Fukuchi M; Oriuchi N; Endo K; Kuwano H
    Ann Surg Oncol; 2010 Dec; 17(12):3181-6. PubMed ID: 20614194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective comparison of
    Lopez R; Gantet P; Salabert AS; Julian A; Hitzel A; Herbault-Barres B; Fontan C; Alshehri S; Payoux P
    J Craniomaxillofac Surg; 2017 Sep; 45(9):1486-1492. PubMed ID: 28764952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET/CT of Hepatosplenic Actinomycosis After Laparoscopic Cystojejunostomy for Pancreatic Pseudocyst.
    Zou Q; Jiao J; Liu WM; Yang T; Zhang Y
    Clin Nucl Med; 2021 Apr; 46(4):e224-e225. PubMed ID: 32910052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical and thoracic actinomycosis on (18)F-FDG PET/CT.
    Singla S; Singh H; Mukherjee A; Karunanithi S; Bal C; Kumar R
    Clin Nucl Med; 2014 Jul; 39(7):623-4. PubMed ID: 24873790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ¹⁸F-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: comparative study with ¹⁸F-FDG PET and immunohistochemistry.
    Miyashita G; Higuchi T; Oriuchi N; Arisaka Y; Hanaoka H; Tominaga H; Morita S; Miyakubo M; Ishikita T; Nakasone Y; Negishi A; Yokoo S; Endo K
    Ann Nucl Med; 2010 Oct; 24(8):579-84. PubMed ID: 20652456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advantages of L-3-[(18)F] fluoro-alpha-methyl tyrosine over 2-[(18)F]-fluoro-2-deoxyglucose in detecting liver metastasis during positron emission tomography scan.
    Kodaira S; Nakajima T; Arisaka Y; Tokue A; Higuchi T; Tsushima Y
    Springerplus; 2016; 5():618. PubMed ID: 27330884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of
    Dolci C; Ceppi L; Guerra L; Crivellaro C; Lamanna M; Adorni M; Elisei F; Bonazzi CM; Sina F; Fruscio R; Messa C
    Int J Gynecol Cancer; 2019 Oct; 29(8):1298-1303. PubMed ID: 31366569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ¹⁸F-FAMT in patients with multiple myeloma: clinical utility compared to ¹⁸F-FDG.
    Isoda A; Higuchi T; Nakano S; Arisaka Y; Kaira K; Kamio T; Mawatari M; Matsumoto M; Sawamura M; Tsushima Y
    Ann Nucl Med; 2012 Dec; 26(10):811-6. PubMed ID: 22903817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [18F]Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) in Suspected Recurrent Breast Cancer: A Prospective Comparative Study of Dual-Time-Point FDG-PET/CT, Contrast-Enhanced CT, and Bone Scintigraphy.
    Hildebrandt MG; Gerke O; Baun C; Falch K; Hansen JA; Farahani ZA; Petersen H; Larsen LB; Duvnjak S; Buskevica I; Bektas S; Søe K; Jylling AM; Ewertz M; Alavi A; Høilund-Carlsen PF
    J Clin Oncol; 2016 Jun; 34(16):1889-97. PubMed ID: 27001573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake of positron emission tomography tracers reflects the tumor immune status in esophageal squamous cell carcinoma.
    Kuriyama K; Higuchi T; Yokobori T; Saito H; Yoshida T; Hara K; Suzuki S; Sakai M; Sohda M; Higuchi T; Tsushima Y; Asao T; Kaira K; Kuwano H; Shirabe K; Saeki H
    Cancer Sci; 2020 Jun; 111(6):1969-1978. PubMed ID: 32302443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.